Evidence map›Paper›PMID 25533872›Full record

Trial reportArthritis & rheumatology (Hoboken, N.J.)2015

Pharmacologic modulation of hand pain in osteoarthritis: a double-blind placebo-controlled functional magnetic resonance imaging study using naproxen.

Duncan Sanders, Kristina Krause, Jonathan O'Muircheartaigh, Michael A Thacker, John P Huggins, William Vennart, Nathalie J Massat, Ernest Choy, Steven C R Williams, Matthew A Howard

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Arthritis & rheumatology (Hoboken, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. The Role of fMRI in Drug Development: An Update.Advances in neurobiology · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. The role of fMRI in drug development.Drug discovery today · 2018
    Review
  15. Review
  16. Osteoarthritis year in review 2015: clinical.Osteoarthritis and cartilage · 2016
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Duncan SandersKing's College London, London, UK; University of Sydney at Royal North Shore Hospital, Sydney, New South Wales, Australia.
Kristina Krause
Jonathan O'Muircheartaigh
Michael A Thacker
John P Huggins
William Vennart
Nathalie J Massat
Ernest Choy
Steven C R Williams
Matthew A Howard
King's College London · GBPfizer (United Kingdom) · GBCardiff University · GBGuy's and St Thomas' NHS Foundation Trust · GBQueen Mary University of London · GBUniversity of Sydney · AU

Funding

Medical Research Council MR/J005142/1
6 · The paper itself

Abstract

objectiveIn an attempt to shed light on management of chronic pain conditions, there has long been a desire to complement behavioral measures of pain perception with measures of underlying brain mechanisms. Using functional magnetic resonance imaging (fMRI), we undertook this study to investigate changes in brain activity following the administration of naproxen or placebo in patients with pain related to osteoarthritis (OA) of the carpometacarpal (CMC) joint.

methodsA placebo-controlled, double-blind, 2-period crossover study was performed in 19 individuals with painful OA of the CMC joint of the right hand. Following placebo or naproxen treatment periods, a functionally relevant task was performed, and behavioral measures of the pain experience were collected in identical fMRI examinations. Voxelwise and a priori region of interest analyses were performed to detect between-period differences in brain activity.

resultsSignificant reductions in brain activity following treatment with naproxen, compared to placebo, were observed in brain regions commonly associated with pain perception, including the bilateral primary somatosensory cortex, thalamus, and amygdala. Significant relationships between changes in perceived pain intensity and changes in brain activity were also observed in brain regions previously associated with pain intensity.

conclusionThis study demonstrates the sensitivity of fMRI to detect the mechanisms underlying treatments of known efficacy. The data illustrate the enticing potential of fMRI as an adjunct to self-report for detecting early signals of efficacy of novel therapies, both pharmacologic and nonpharmacologic, in small numbers of individuals with persistent pain.

Indexed as

AgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalCarpometacarpal JointsCross-Over StudiesDouble-Blind MethodFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNaproxenOsteoarthritisPainPain MeasurementAnti-Inflammatory Agents, Non-SteroidalNaproxen

Identifiers

PMID25533872
PMCPMC4365729
OpenAlexW2159386313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.